Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.73 CAD | -1.04% | -1.37% | +10.60% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.60% | 429M | |
+3.37% | 69.85B | |
+11.77% | 8.98B | |
-12.75% | 4.89B | |
+42.38% | 4.44B | |
+5.23% | 3.95B | |
+21.69% | 2.49B | |
-19.05% | 2.4B | |
-28.72% | 2.28B | |
+11.13% | 1.96B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Seeking Brazilian Approvals for the Pemigatinib Cancer Treatment